Data and Quality Initiatives: Addressing a Costly and Deadly Condition

Product not yet rated

Recorded On: 06/23/2021

Webinar Description: 

This panel discussion reviews assay biological pathways, sepsis progression, and immune system collapse. It will explore the role of molecular diagnostics in sepsis workflow and how to implement effective sepsis protocols in the lab and hospital practice. Learn about the impact of COVID-19 and viral sepsis on new technology development. Clinical, policy, legislative, and regulatory perspectives and new developments in that space will be shared.

This course was originally recorded in June 2021 as part of Sepsis Tech & Innovation. 

Target Audience:

Industry leaders, Public Policy Experts, Health and hospital Leadership (C-Suite, physicians, nurses, pharmacists, CIOs), Health quality and decision support leaders, Health Investors and VCs, Health and Technology Media, Health Advocates, Health Advisors, Health Educators, Health Marketers. 

Hallie Prescott, MD, MSc

Associate Professor

University of Michigan

Dr. Hallie Prescott is an Associate Professor in Pulmonary & Critical Care Medicine at the University of Michigan and staff physician at the Ann Arbor Veterans Affairs Hospital. She is an expert in long-term outcomes and recovery after sepsis. Her research program has been funded by AHRQ, NIH, and Department of Veterans Affairs. She is a vice-chair of the Surviving Sepsis Campaign guidelines, council member of the International Sepsis Forum, and physician-lead for a BlueCross/Blue Shield of Michigan sepsis quality improvement consortium of 50 Michigan hospitals.

Amy McKenzie, MD, MBA

Vice President, Clinical Partnerships and Associate CMO

Blue Cross Blue Shield of Michigan

Amy McKenzie, MD, MBA is a board-certified family medicine physician with 13 years of experience in private practice and over ten years of experience in healthcare administration and clinical leadership. Dr. McKenzie joined Blue Cross Blue Shield of Michigan in 2013 as a physician consultant supporting Quality Management and Accreditation and is now the Associate Chief Medical Officer and Vice President leading Clinical Partnerships. Her team is responsible for providing clinical leadership for provider value-based programs and risk contracting and helps to enable and support the network through education, communication, and partnering on practice transformation efforts. She also leads the Behavioral Health Strategy and Planning team responsible for development and implementation of the BH strategy. Dr. McKenzie graduated from Northeast Ohio Medical University and completed her residency at Ascension Providence Hospital in Southfield, Michigan. In 2017, she received her MBA with a focus in medical management from the University of Massachusetts Amherst. She is currently serving as Vice Chair on the State of Michigan Certificate of Need Commission and is a past president on the Family Medicine Foundation of Michigan.

John Syrjamaki, MPH

Manager, Data Analytics, Department of Surgery

University of Michigan

John Syrjamaki is the Manager of Data Analytics for the Michigan Value Collaborative (MVC) and a member of the Department of Surgery at the University of Michigan. After graduating from Michigan State University with a Bachelor of Science in Physiology, Mr. Syrjamaki earned a Master of Public Health in Environmental Health Sciences and Toxicology from the University of Michigan. He is responsible for leading all analytic and data-related efforts of the Collaborative, including the creation of custom performance reports and management of the online MVC data platform. He provides direct analytic consulting services to 87 member hospitals and 40 physician organizations, manages partnerships with other Blue Cross Blue Shield of Michigan (BCBSM) Collaborative Quality Initiatives (CQIs), and works closely with BCBSM and outside vendors concerning data needs and improvements.

Scott Flanders, MD

Chief Clinical Strategy Officer

Michigan Medicine

Scott Flanders, MD, Professor of Internal Medicine, serves as Chief Clinical Strategy Officer for Michigan Medicine, Vice Chair of External Relations in the Department of Internal Medicine, and is a hospitalist in the Division of Hospital Medicine. Dr. Flanders was a founding member of the Board of Directors of the Society of Hospital Medicine (SHM) and is a Past President of SHM. He received his Medical Degree from the University of Chicago Pritzker School of Medicine and completed his residency and chief residency at the University of California, San Francisco.

Components visible upon registration.